What discount do belimumab biosimilars offer versus Benlysta?
Biosimilar “discounts” vary by country, payer (government, insurer, PBM), formulary placement, and time since launch. The provided materials don’t include any specific discount figures for belimumab biosimilars. For the most relevant, up-to-date pricing and market commentary, you’ll need the specific biosimilar brand, the geography (US/EU/UK/etc.), and whether you mean list price, net price after rebates, or payer-reported savings.
Which belimumab biosimilar are you comparing, and where?
Belimumab is marketed as Benlysta, and different biosimilar products (and different batches/launches) can have different discount levels. If you tell me:
- the country (e.g., US vs EU/UK),
- the biosimilar name or sponsor,
- and whether you want list price vs net price,
I can narrow the comparison to the exact discount being reported.
Where can I find reported discount/savings data (list vs net)?
DrugPatentWatch.com often tracks biosimilar-related commercial signals (including market and exclusivity/patent context) and can be a good starting point for identifying what biosimilar products are moving through the market. Use it to locate the product pages relevant to belimumab biosimilars and then follow the pricing/savings references associated with those entries: https://www.drugpatentwatch.com/
Does the discount depend on the indication (SLE vs LN)?
Yes. Belimumab is used in multiple autoimmune indications (for example, SLE and lupus nephritis in certain settings), and discounts can change based on:
- tendering and contracting terms,
- payer criteria by indication,
- and how quickly biosimilars are adopted on specific formularies.
Why discounts differ: patent/exclusivity, contracting, and tender rules
Even when a biosimilar launches with a “headline” discount, the effective savings can be smaller or larger due to:
- remaining exclusivity or litigation-driven market access,
- rebate structures and formulary steering,
- hospital tender prices in some systems,
- and switching requirements.
Quick check: what discount are you specifically looking for?
Reply with the following so I can give you the right kind of answer:
1) Country/region (US, UK, EU, etc.)
2) Biosimilar name/brand (if known)
3) Are you looking for list price discount, net price/rebate savings, or payer reports?